The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening
Cancer · 15.09.2025 · 131 (18)
DOI: 10.1002/cncr.35972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 10.09.2025. Verfasst von Joelle T Fathi und 13 weiteren Autor:innen. Beteiligte Einrichtung: GO2 for Lung Cancer, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Smoking Cessation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 144 Literaturangaben. Gefördert von: American Cancer Society National Lung Cancer Roundtable, AbbVie, Amgen.
Abstract (Originalsprache)
Tobacco use is the primary contributor to disease and death in the United States, and cigarette smoking is the leading risk factor for lung cancer. Safe and effective treatments for tobacco dependence exist; however, access to and use of tobacco treatment remains low. The most recent Centers for Medicare and Medicaid Services National Coverage Determination requires a shared decision‐making visit for lung cancer screening that includes counseling on the importance of maintaining cigarette smoking abstinence if a person formerly smoked; or the importance of smoking cessation if a person currently smokes and, if appropriate, furnishing of information about tobacco‐cessation interventions. The directive is not well defined and provides little guidance for delivering high‐quality cessation services. Effective integration of best practices for tobacco treatment in the context of lung cancer screening must extend far beyond recommendations to quit, patient literature to reinforce quitting, and available evidence‐based treatments. To optimize the provision of tobacco treatment and improve health outcomes in people being screened for lung cancer, the American Cancer Society National Lung Cancer Roundtable Tobacco Treatment in the Context of Lung Cancer Screening Task Group recommends: (1) specify quality indicators and document tobacco treatment delivery; (2) embed tobacco treatment in lung cancer screening; (3) advocate for increased access to tobacco treatment; (4) build and train lung cancer screening staff; (5) provide full coverage of treatment medications; (6) leverage electronic health records to improve the provision of cessation services to lung cancer screenees; and (7) identify and address contextual barriers to incorporating tobacco treatment guidelines in screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- GO2 for Lung Cancer, Washington, District of Columbia, USA.
- Department of Biobehavioral Nursing and Health Informatics, School of Nursing, University of Washington, Seattle, Washington, USA.
- Unit 1330, Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- American Lung Association, Chicago, Illinois, USA.
- Department of Family Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
- Department of Medicine, University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID-Profile: Joelle T Fathi, Paul M Cinciripini, Madeline J DePrimo, Thomas P Houston, Hasmeena Kathuria, Elyse R Park, Bradley B Pua, Theresa M Roelke, Kathryn L Taylor, Benjamin A Toll, Steve Zeliadt, Ella A Kazerooni, Robert A Smith, Jamie S Ostroff
Förderung
- American Cancer Society National Lung Cancer Roundtable
- AbbVie
- Amgen
- AstraZeneca
- Boehringer Ingelheim
- Bristol Myers Squibb Company
- Daiichi-Sankyo Company
- Foundation Medicine
Zitieren
APA
Fathi, J. T., Cinciripini, P. M., DePrimo, M. J., Houston, T. P., Kathuria, H., Park, E. R., Pua, B. B., Roelke, T. M., Taylor, K. L., Toll, B. A., Zeliadt, S., Kazerooni, E. A., Smith, R. A., & Ostroff, J. S. (2025). The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening. Cancer, 131(18). https://doi.org/10.1002/cncr.35972
Vancouver
Fathi JT, Cinciripini PM, DePrimo MJ, Houston TP, Kathuria H, Park ER, et al. The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening. Cancer. 2025;131(18). doi:10.1002/cncr.35972
BibTeX
@article{Fathi2025,
author = {Fathi, Joelle T and Cinciripini, Paul M and DePrimo, Madeline J and Houston, Thomas P and Kathuria, Hasmeena and Park, Elyse R and Pua, Bradley B and Roelke, Theresa M and Taylor, Kathryn L and Toll, Benjamin A and Zeliadt, Steve and Kazerooni, Ella A and Smith, Robert A and Ostroff, Jamie S},
title = {The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening},
journal = {Cancer},
year = {2025},
volume = {131},
number = {18},
doi = {10.1002/cncr.35972}
}
EUVIMED